Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,58 USD | -0,77% | +1,18% | +3,20% |
Omzet 2024 * | 14,23 mln. 10,49 mln. 9,74 mln. | Omzet 2025 * | 13,59 mln. 10,02 mln. 9,31 mln. | Marktkapitalisatie | 627 mln. 462 mln. 429 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -111 mln. -81,85 mln. -76,01 mln. | Nettowinst (verlies) 2025 * | -130 mln. -95,86 mln. -89,02 mln. | EV/omzet 2024 * | 44 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 46,1 x |
K/w-verhouding 2024 * |
-5,76
x | K/w-verhouding 2025 * |
-4,85
x | Werknemers | 73 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 76,57% |
Recentste transcriptie over Arbutus Biopharma Corporation
1 dag | -0,77% | ||
1 week | +1,18% | ||
Lopende maand | -7,86% | ||
1 maand | -10,42% | ||
3 maanden | +1,57% | ||
6 maanden | +29,00% | ||
Lopend jaar | +3,20% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 49 | 01-07-14 | |
David Hastings
DFI | Director of Finance/CFO | 62 | 11-06-18 |
Karen Sims
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 68 | 01-12-14 | |
James Meyers
BRD | Director/Board Member | 58 | 23-10-18 |
Daniel Burgess
BRD | Director/Board Member | 62 | 23-03-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.03% | 0 M€ | 0,00% | - | |
0.03% | 0 M€ | 0,00% | - | |
0.03% | 2 M€ | -.--% | ||
0.02% | 7 M€ | -.--% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 2,58 | -0,77% | 525 829 |
27-03-24 | 2,6 | +4,42% | 830 398 |
26-03-24 | 2,49 | 0,00% | 375 260 |
25-03-24 | 2,49 | -0,40% | 336 379 |
22-03-24 | 2,5 | -1,96% | 335 599 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,20% | 467 mln. | |
+0,44% | 90,27 mld. | |
+9,61% | 44,05 mld. | |
-16,67% | 31,45 mld. | |
+44,99% | 23,35 mld. | |
-9,42% | 16,72 mld. | |
-25,92% | 15,09 mld. | |
-9,27% | 12,82 mld. | |
-7,57% | 11,95 mld. | |
+0,07% | 8,71 mld. |